Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The glycosylation of the circulating immunoglobulin-gamma (IgG) antibody molecules changes in rheumatoid arthritis. The extent of the changes correlates with the disease severity and reverses in remission. We demonstrate here that the alteration in glycosylation associated with rheumatoid arthritis can create a new mode for the interaction of IgG with complement through binding to the collagenous lectin mannose-binding protein (MBP). Rheumatoid arthritis is associated with a marked increases in IgG glycoforms that lack galactose (referred to as G0 glycoforms) in the Fc region of the molecule and that terminate in N-acetyl glucosamine (GlcNAc). We show, using nuclear magnetic resonance (NMR) and X-ray data, that these terminal GlcNAc residues become accessible for MBP binding. We further demonstrate that multiple presentation of IgG-G0 glycoforms to MBP results in activation of the complement. This suggests that a contribution to the chronic inflammation of the synovial membrane could arise from the localization of the IgG-G0 glycoforms in the affected joint and from resulting activation of complement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
Meiboom, S., & Gill, D. (1958) · Review of Scientific Instruments · doi:10.1063/1.1716296 · Cited by 6,022
The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
Porter, R. R. (1959) · Biochemical Journal · doi:10.1042/bj0730119 · Cited by 2,308
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Self-citationStructure of a C-type mannose-binding protein complexed with an oligosaccharide
Weis, W. I., Drickamer, K., & Hendrickson, W. A. (1992) · Nature · doi:10.1038/360127a0 · Cited by 885
The binding site for C1q on IgG
Duncan, A. R., & Winter, G. (1988) · Nature · doi:10.1038/332738a0 · Cited by 569
Drickamer, K., Dordal, M. S., & Reynolds, L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62698-0 · Cited by 429
Serum lectin with known structure activates complement through the classical pathway.
Ikeda, K., Sannoh, T., Kawasaki, N., Kawasaki, T., & Yamashina, I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47587-4 · Cited by 424
Trimeric structure of a C-type mannose-binding protein
Weis, W. I., & Drickamer, K. (1994) · Structure · doi:10.1016/s0969-2126(94)00124-3 · Cited by 307
Research works printed but not linked: 2
- Chang, S.-C. Altered Glycosylation in Immunoglobulin G and Its Fragments in Rheumatoid Arthritis. thesis, Oxford (1993).
- Parekh, R.B. A Study of the Structure and Biosynthesis of N-linked Oligosaccharides and of their Involvement in Certain Diseases. thesis, Oxford Univ.(1987).
Cited by
Items 101–200 of 844
Mannan-binding lectin?a soluble pattern recognition molecule
Gadjeva, M. G., Takahashi, K., & Thiel, S. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.015 · Cited by 155
Collectins and collectin receptors in innate immunity
Holmskov, U. L. (2000) · APMIS · doi:10.1111/j.1600-0463.2000.tb05694.x · Cited by 138
Gornik, O., Štambuk, T., & Lauc, G. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.004 · Cited by 162
“Incomplete galactosylation of IgG can activate complement via the mannose-binding protein and thus be part of the underlying pathological mechanism [47,48].”
BackgroundNandakumar, K. S., & Holmdahl, R. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2089 · Cited by 154
“An association between RA and an increase in IgG glycoforms lacking galactose in the Fc region has been demonstrated [24,25], which correlated with disease activity [26].”
BackgroundThe structural role of sugars in glycoproteins
Wyss, D. F., & Wagner, G. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80116-9 · Cited by 154
The Complement System in Schizophrenia
(2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.4.1213349 · Cited by 139
Self-citationThe role of sialic acid as a modulator of the anti-inflammatory activity of IgG
Böhm, S., Schwab, I., Lux, A., & Nimmerjahn, F. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0308-x · Cited by 152
Chen, G., Wang, Y., Qiu, L., Qin, X., Liu, H., Wang, X., Wang, Y., Song, G., Li, F., Guo, Y., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.02.001 · Cited by 151
“Marked increase in agalactosylated IgG with both outer-arms terminating in N-acetylglucosamine (GlcNAc) or mannose has been demonstrated in many autoimmune diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), juvenile onset chronic arthritis and Crohn's disease [1,3–6], suggesting important…”
BackgroundInfluentialBeck, A., Bussat, M., Zorn, N., Robillard, V., Klinguer, C., Chenu, S., Goetsch, L., Corvaïa, N., DORSSELAER, A. V., & Haeuw, J. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.06.052 · Cited by 147
Murata, K., & Baldwin, W. M. (2009) · Transplantation Reviews · doi:10.1016/j.trre.2009.02.005 · Cited by 147
“The MBL can bind to the exposed Nacetyl glucosamine on the G0 isoforms of IgG and activate complement [25].”
BackgroundA mathematical model of N-linked glycoform biosynthesis
Umaña, P., & Bailey, J. E. (1997) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19970920)55:6<890::aid-bit7>3.0.co;2-b · Cited by 126
Radcliffe, C. M., Arnold, J. N., Suter, D. M., Wormald, M. R., Harvey, D. J., Royle, L., Mimura, Y., Kimura, Y., Sim, R. B., Inogés, S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602690200 · Cited by 145
Self-citationAntibody Glycosylation and Inflammation
Shade, K.-T., & Anthony, R. M. (2013) · Antibodies · doi:10.3390/antib2030392 · Cited by 143
“Compared to healthy individuals, there is a marked increase of agalactosylated and asialylated serum IgG in individuals with autoimmune diseases [51,78–81], infectious diseases [81,82] and tumours [83,84].”
BackgroundEstrogens regulate glycosylation of IgG in women and men
Ercan, A., Kohrt, W. M., Cui, J., Deane, K. D., Pezer, M., Yu, E. W.-Y., Hausmann, J. S., Campbell, H. J., Kaiser, U. B., Rudd, P. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89703 · Cited by 142
“G0 glycans enable IgG to engage mannose binding lectin, enhancing complement fixation via the lectin pathway (4, 24).”
BackgroundSelf-citationYu, X., Wang, Y., Kristic, J., Dong, J., Chu, X., Ge, S., Wang, H., Fang, H., Gao, Q., Liu, D., et al. (2016) · Medicine · doi:10.1097/md.0000000000004112 · Cited by 128
“The reduction of terminal galactose residues was suggested as a mechanism to enhance the proinflammatory activity in vitro.([42]) Our study was consistent with that hypothesis by observing a lower level of galactosylation in males who had a higher WBC, a classic clinical inflammatory index, than that in females.”
ResultBones, J., Byrne, J. C., O'Donoghue, N. M., McManus, C. A., Scaife, C., Boissin, H., Năstase, A., & Rudd, P. M. (2010) · Journal of Proteome Research · doi:10.1021/pr101036b · Cited by 139
Self-citationIgG and Fcγ Receptors in Intestinal Immunity and Inflammation
Castro‐Dopico, T., & Clatworthy, M. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00805 · Cited by 144
“G0 IgG can activate complement via binding to mannose binding lectin and can bind the mannose receptor on phagocytes (46, 47).”
BackgroundT cell–independent B cell activation induces immunosuppressive sialylated IgG antibodies
Hess, C., Winkler, A., Lorenz, A. K., Holecska, V., Blanchard, V., Eiglmeier, S., Schoen, A.-L., Bitterling, J., Stoehr, A. D., Petzold, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65938 · Cited by 126
Molecular Pathogenesis of Membranous Nephropathy
Ronco, P. M., & Dêbiec, H. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043811 · Cited by 135
Naturally occurring glycan forms of human immunoglobulins G1 and G2
Flynn, G. C., Chen, X., Liu, D., Shah, B., & Zhang, Z. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.04.006 · Cited by 138
“But for rheumatoid arthritis, the dominant glycans have been shown to interact more strongly with the mannose binding protein, leading investigators to propose a link to complement activation and disease related tissue damage (Malhotra et al., 1995).”
BackgroundHydrophilic Mesoporous Silica Materials for Highly Specific Enrichment of N-Linked Glycopeptide
Sun, N., Wang, J., Yao, J., & Deng, C. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04054 · Cited by 134
Elevated Levels of Mannan-Binding Lectin in Patients with Type 1 Diabetes
Hansen, T. K., Thiel, S., Knudsen, S. T., Gravholt, C. H., Christiansen, J. S., Mogensen, C. E., & Poulsen, P. L. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030742 · Cited by 133
Glycobiology: More Functions for Oligosaccharides
Dwek, R. A. (1995) · Science · doi:10.1126/science.7652569 · Cited by 131
Self-citationRegulated Glycosylation Patterns of IgG during Alloimmune Responses against Human Platelet Antigens
Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C. A. M., Deelder, A. M., de Haas, M., & Vidarsson, G. (2009) · Journal of Proteome Research · doi:10.1021/pr800651j · Cited by 119
A New Classification System for IgG4 Autoantibodies
Koneczny, I. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00097 · Cited by 128
Glomerular deposition of mannose-binding lectin in human glomerulonephritis
Lhotta, K., Würzner, R., & König, P. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.4.881 · Cited by 128
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis
Rijnink, W. F., Ottenhoff, T. H. M., & Joosten, S. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640168 · Cited by 129
“Although the absence of galactose is considered to be correlated with increased inflammatory activity in general (223, 226), agalactosylated (G0) IgG could trigger the lectin complement pathway (230).”
BackgroundRegulation of complement and modulation of its activity in monoclonal antibody therapy of cancer
Meyer, S., Leusen, J. H., & Boross, P. (2014) · mAbs · doi:10.4161/mabs.29670 · Cited by 109
“Modifications of the carbohydrate structure leading to the exposure of mannose, GlcNAc and fucose, but not glucose, have resulted in the ability of MBL binding and the activation of the MBL pathway in vitro.(109) Antibodies carrying terminal mannose residues do not bind C1q.”
BackgroundInflammatory etiopathogenesis of systemic lupus erythematosus: an update
i, M. H., Podolska, M. J., Biermann, M. H. C., Maueröder, C., & Hahn, J. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s70325 · Cited by 127
“90 In contrast, the loss of terminal galactose in the Fc part of IgG results in increased complement activation 91 favoring the clearance of dead cell remnants, and the absence of terminal sialic acid reportedly suppresses antibody-dependent cell-mediated cytotoxicity.”
The B cell response to citrullinated antigens in the development of rheumatoid arthritis
Scherer, H. U., Huizinga, T. W. J., Krönke, G., Schett, G. A., & Toes, R. E. M. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.10 · Cited by 125
Immunopathogenesis of membranous nephropathy: an update
Dêbiec, H., & Ronco, P. M. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0423-y · Cited by 123
“However, when the N-glycans attached to the fragment crystallizable region (Fc) of IgG terminate with a GlcNAc residue, MBL can bind to IgG and activate the lectin pathway [151].”
BackgroundNovel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases
Dekkers, G., Rispens, T., & Vidarsson, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00553 · Cited by 125
“One study proposed that activation of complement by these agalactosylated IgG species involves specific recognition by the mannose-binding lectin and activation through the lectin pathway of complement activation (94).”
BackgroundMüthing, J., Kemminer, S. E., Conradt, H. S., Šagi, D., Nimtz, M., Kärst, U., & Peter‐Katalinić, J. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10673 · Cited by 105
Impact of autoantibody glycosylation in autoimmune diseases
Goulabchand, R., Vincent, T., Batteux, F., Eliaou, J., & Guilpain, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.02.005 · Cited by 120
Binding and Uptake of Agalactosyl IgG by Mannose Receptor on Macrophages and Dendritic Cells
Dong, X., Storkus, W. J., & Salter, R. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5427 · Cited by 110
Arnold, J. N., Radcliffe, C. M., Wormald, M. R., Royle, L., Harvey, D. J., Crispin, M., Dwek, R. A., Sim, R. B., & Rudd, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6831 · Cited by 110
“The IgG-G0 glycoforms have been shown to bind MBL (5)”
BackgroundSelf-citationGlycobiology of rheumatic diseases
Kissel, T., Toes, R. E. M., Huizinga, T. W. J., & Wuhrer, M. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00867-4 · Cited by 119
Dobó, J., Kocsis, A., Farkas, B., Demeter, F., Cervenak, L., & Gál, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031566 · Cited by 120
“The natural inhibitor of the LP, C1INH, can be adopted as a therapeutic agent.”
BackgroundThe Role of Antibodies in Mouse Models of Rheumatoid Arthritis, and Relevance to Human Disease
Monach, P. A., Benoist, C. O., & Mathis, D. J. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)82005-4 · Cited by 118
The Lectin Pathway of the Complement System
Matsushita, M. (1996) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1996.tb01156.x · Cited by 118
Nandakumar, K. S., Collin, M., Olsén, A., Nimmerjahn, F., Blom, A. M., Ravetch, J. V., & Holmdahl, R. (2007) · European Journal of Immunology · doi:10.1002/eji.200737581 · Cited by 118
Graudal, N. A., MADSEN, H. O., Tarp, U., Svejgaard, A., Jurik, A. G., Graudal, H. K., & Garred, P. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<515::aid-anr6>3.0.co;2-t · Cited by 116
Saevarsdottir, S., Oskarsson, O. O., Aspelund, T., Eiriksdottir, G., Vikingsdottir, T., Gudnason, V., & Valdimarsson, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041431 · Cited by 109
“MBL has high affinity for GlcNAc (10) and has been shown to bind glycoproteins with terminal GlcNAc residues (38, 39).”
BackgroundGhirlando, R., Lund, J., Goodall, M. D., & Jefferis, R. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00029-2 · Cited by 115
Sonneveld, M. E., Natunen, S., Sainio, S., Koeleman, C. A. M., Holst, S., Dekkers, G., Koelewijn, J. M., Partanen, J., van der Schoot, C. E., Wuhrer, M., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14053 · Cited by 117
Regulation of antibody effector functions through IgG Fc N-glycosylation
Quast, I., Peschke, B., & Lünemann, J. D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2366-z · Cited by 120
Garred, P., Pressler, T., Lanng, S., MADSEN, H. O., Moser, C. E., Laursen, I., Balstrup, F., Koch, C., & Koch, C. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10064 · Cited by 114
Massey, H. D., & McPherson, R. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00047-6 · Cited by 113
Oortwijn, B. D., Roos, A., Royle, L., van Gijlswijk‐Janssen, D. J., Faber‐Krol, M. C., Eijgenraam, J., Dwek, R. A., Daha, M. R., Rudd, P. M., & van Kooten, C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040388 · Cited by 113
“This undergalactosylated IgA1 may lead to generation of circulating IgG–IgA1 complexes (20).”
InfluentialSelf-citationBallanti, E., Perricone, C., Muzio, G. D., Kroegler, B., Chimenti, M. S., Graceffa, D., & Perricone, R. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.012 · Cited by 112
“Changes in glycosylation of IgG in RA cause an increase in binding of mannosebinding lectin resulting in increased complement activation [57].”
BackgroundElbers, I. J. W., Stoopen, G. M., Bakker, H., Stevens, L. H., Bardor, M., Molthoff, J. W., Jordi, W., Bosch, D., & Lommen, A. (2001) · PLANT PHYSIOLOGY · doi:10.1104/pp.126.3.1314 · Cited by 111
“It has been documented that physiological and environmental factors can have profound effects on glycosylation in mammals (Malhotra et al., 1995; van Dijk et al., 1995).”
BackgroundGlycosylation and Fc Receptors
Hayes, J. M., Cosgrave, E. F. J., Struwe, W. B., Wormald, M., Davey, G. P., Jefferis, R., & Rudd, P. M. (2014) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-07911-0_8 · Cited by 110
“activate complement (Malhotra et al. 1995), galactose residues are involved in”
BackgroundSelf-citationNimmerjahn, F., Vidarsson, G., & Cragg, M. S. (2023) · Nature Immunology · doi:10.1038/s41590-023-01544-8 · Cited by 112
N-Glycan Profile and Kidney Disease in Type 1 Diabetes
Bermingham, M. L., Colombo, M., McGurnaghan, S. J., Blackbourn, L. A. K., Vučković, F., Pučić Baković, M., Trbojević-Akmačić, I., Lauc, G., Agakov, F., Agakova, A. S., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1042 · Cited by 100
“glomerular deposition of immune complexes (33).”
Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals
Moore, J. S., Wu, X., Kulhavy, R., Tomana, M., Novak, J., Moldoveanu, Z., Brown, R., Goepfert, P. A., & Mestecky, J. (2005) · AIDS · doi:10.1097/01.aids.0000161767.21405.68 · Cited by 108
“These studies, with emphasis on immunoglobulin molecules, convincingly demonstrated that galactosedeficient IgG and IgAmolecules displayed a propensity to self-aggregation [2]; an efficient activation of the complement cascade through the lectin pathway [1,3,35]; a longer or shorter half-life in the circulation, depen…”
BackgroundHypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis
HOLLAND, M., TAKADA, K., OKUMOTO, T., TAKAHASHI, N., KATO, K., ADU, D., BEN-SMITH, A., HARPER, L., SAVAGE, C. O. S., & JEFFERIS, R. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01864.x · Cited by 97
Sugar-mediated ligand–receptor interactions in the immune system
Rudd, P. M., Wormald, M. R., & Dwek, R. A. (2004) · Trends in biotechnology · doi:10.1016/j.tibtech.2004.07.012 · Cited by 108
Self-citationEspy, C., Morelle, W., Kavian, N., Grange, P., Goulvestre, C., Viallon, V., Chéreau, C., Pagnoux, C., Michalski, J.-C., Guillevin, L., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30362 · Cited by 97
“In contrast, those authors have shown that the activity of these antibody glycovariants is fully dependent on the presence of activating Fc receptors, and that asialylated antibodies result in enhanced Fc receptor binding and, thus, enhanced pathogenicity in vivo (35,36).”
Mannose binding lectin: Genetics and autoimmune disease
Tsutsumi, A., Takahashi, R., & Sumida, T. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.02.004 · Cited by 108
Gudelj, I., Salo, P. P., Trbojević‐Akmačić, I., Albers, M., Primorac, D., Perola, M., & Lauc, G. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.018 · Cited by 108
Phospholipase A2 Receptor–Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency
Bally, S., Dêbiec, H., Ponard, D., Dijoud, F., Rendu, J., Fauré, J., Ronco, P. M., & Dumestre‐Pérard, C. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015101155 · Cited by 107
Glycobiology: 'the function of sugar in the IgG molecule'.
Dwek, R. A., Lellouch, A. C., & Wormald, M. R. (1995) · PubMed Central · Cited by 107
Self-citationStructural changes in the oligosaccharide moiety of human IgG with aging
Shikata, K., Yasuda, T., Takeuchi, F., Konishi, T., Nakata, M., & Mizuochi, T. (1998) · Glycoconjugate Journal · doi:10.1023/a:1006936431276 · Cited by 106
Kemna, M. J., Plomp, R., van Paassen, P., Koeleman, C. A. M., Jansen, B. C., Damoiseaux, J. G. M. C., Tervaert, J. W. C., & Wuhrer, M. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.033 · Cited by 106
“, 2015) and can influence complement activation (Malhotra et al., 1995).”
BackgroundThe recognition of glycans by protein receptors. Insights from NMR spectroscopy
Ardá, A., & Jiménez‐Barbero, J. (2018) · Chemical Communications · doi:10.1039/c8cc01444b · Cited by 106
Baudino, L., da Silveira, S. A., Nakata, M., & Izui, S. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0037-0 · Cited by 104
“A previous publication on agalactosylated IgG from patients with rheumatoid arthritis has claimed that exposure of Nacetylgucosamine by agalactosylated IgG could result in an interaction with mannose-binding lectin, thereby activating complement cascade [36].”
Kumpel, B. M. (2007) · Vox Sanguinis · doi:10.1111/j.1423-0410.2007.00945.x · Cited by 104
Johnson, M., Rees, I. H., Robertson, B. D., TURNER, M. W., Klein, N. J., & Jack, D. L. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.3894-3899.2000 · Cited by 104
Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi
Cestari, I. D. S., Krarup, A., Sim, R. B., Inal, J. M., & Ramirez, M. I. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.08.030 · Cited by 103
Self-citationKurogochi, M., Mori, M., Osumi, K., Tojino, M., Sugawara, S.-I., Takashima, S., Hirose, Y., Tsukimura, W., Mizuno, M., Amano, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132848 · Cited by 96
“0195 μg/mL), which is initiated by the IgG Fc region binding to C1q (complement component 1q) [15, 17] and mannose-binding protein [64, 65], which structurally resembles C1q, and not the affinity of FcγRIIIa on effector cells at the middle concentration range (0.”
BackgroundKelly, P. M., Jack, D. L., Naeem, A., Mandanda, B., Pollok, R., Klein, N. J., TURNER, M. W., & Farthing, M. J. G. (2000) · Gastroenterology · doi:10.1053/gast.2000.19573 · Cited by 102
The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals
Krištić, J., & Lauc, G. (2024) · Immunological Reviews · doi:10.1111/imr.13407 · Cited by 103
“106 However, an in vivo study with MBL-null mice demonstrated that galactose-deficient IgG antibodies from arthritic animals can induce arthritis in both mice that lack MBL and wild-type mice.”
Antibody glycosylation in autoimmune diseases
Zhou, X., Motta, F., Selmi, C. F., Ridgway, W. M., Gershwin, M. E., & Zhang, W. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102804 · Cited by 100
The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo
Anthony, R. M., & Nimmerjahn, F. (2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328342538f · Cited by 93
The structure and origin of rheumatoid factors
Sutton, B. J., Corper, A. L., Bonagura, V. R., & Taussig, M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01589-9 · Cited by 100
Kunkel, J. P., Jan, D. C.-H., Butler, M., & Jamieson, J. (2000) · Biotechnology Progress · doi:10.1021/bp000026u · Cited by 99
“10.1021/bp000026u CCC: $19.00 © 2000 American Chemical Society and American Institute of Chemical Engineers Published on Web 05/10/2000 The Fc glycans of IgG are essential to the structural integrity of the antibody (Matsuda et al., 1990; Malhotra et al., 1995; Wormald et al., 1997).”
BackgroundInfluentialMa, W., Xu, L., Li, Z., Sun, Y., Bai, Y., & Liu, H. (2016) · Nanoscale · doi:10.1039/c6nr02490d · Cited by 98
The other side of immunoglobulin G: suppressor of inflammation
Aschermann, S., Lux, A., Baerenwaldt, A., Biburger, M., & Nimmerjahn, F. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04081.x · Cited by 91
Sweet but dangerous – the role of immunoglobulin G glycosylation in autoimmunity and inflammation
Biermann, M. H. C., Griffante, G., Podolska, M. J., Boeltz, S., Stürmer, J., Munoz, L. E., Bilyy, R. O., & i, M. H. (2016) · Lupus · doi:10.1177/0961203316640368 · Cited by 100
Pairing of oligosaccharides in the Fc region of immunoglobulin G
Masuda, K., Yamaguchi, Y., Kato, K., Takahashi, N., Shimada, I., & Arata, Y. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01557-x · Cited by 91
Kapingidza, A. B., Kowal, K., & Chruszcz, M. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-41769-7_19 · Cited by 100
Mannose-Binding Lectin and Mortality in Type 2 Diabetes
Hansen, T. K., Gall, M.-A., Tarnow, L., Thiel, S., Stehouwer, C. D. A., Schalkwijk, C. G., Parving, H.-H., & Flyvbjerg, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.18.2007 · Cited by 96
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins
Moore, J., Kulhavy, R., Tomana, M., Moldoveanu, Z., Suzuki, H., Brown, R., Hall, S. D., Kilian, M., Poulsen, K., Mestecky, J. F., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.12.011 · Cited by 95
Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy
Mestecky, J. F., Tomana, M., Moldoveanu, Z., Julian, B. A., Suzuki, H., Matoušovic, K., Renfrow, M. B., Novak, L., Wyatt, R. J., & Novák, J. (2008) · Kidney & Blood Pressure Research · doi:10.1159/000112922 · Cited by 95
“In contrast, supplementation with a larger quantity of this IgA1 inhibited cellular proliferation in assays using serum fractions of M r 700–800 kDa. In summary, these findings suggest that CIC containing aberrantly glycosylated IgA1 affect proliferation of mesangial cells in vitroand thus likely play a role in the pa…”
BackgroundGlycans Instructing Immunity: The Emerging Role of Altered Glycosylation in Clinical Immunology
Lyons, J. J., Milner, J. D., & Rosenzweig, S. D. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00054 · Cited by 93
Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins
Vasseur, J. A., Goetz, J. A., Alley, W. R., & Novotný, M. V. (2012) · Glycobiology · doi:10.1093/glycob/cws108 · Cited by 93
“…(Alley, Vasseur, et al. 2012; Svoboda et al. 2012), these types of structures are mainly associated with IgG, whereas the galactosylated structures appear to be important in the mannose-binding lectin mechanism to activate the complement factor response (Malhotra et al. 1995; Rudd et al. 1995).”
BackgroundLiu, D., & Niu, Z.-X. (2009) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970902845768 · Cited by 79
“(21–23) In addition, though, the protein cytokeratin, when it is exposed on ischemic endothelial cells(24) also activates this pathway, as can antibodies bearing a specific form of agalactosyl carbohydrate designated G0.”
BackgroundWatson, M., Rudd, P. M., Bland, M., Dwek, R. A., & Axford, J. S. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1682::aid-anr17>3.0.co;2-x · Cited by 93
Self-citationSugar Determines Antibody Activity
Burton, D. R., & Dwek, R. A. (2006) · Science · doi:10.1126/science.1131712 · Cited by 92
Self-citationHmiel, L. K., Brorson, K., & Boyne, M. T. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8108-x · Cited by 92
“An inverse relationship seems to exist between galactosylation and inflammation when studied in human populations [62, 63].”
BackgroundC1, MBL–MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation
Beinrohr, L., Dobó, J., Závodszky, P., & Gál, P. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.009 · Cited by 92
The James Blundell Award Lecture 2007: Do we really understand immune red cell destruction?
Garratty, G. (2008) · Transfusion Medicine · doi:10.1111/j.1365-3148.2008.00891.x · Cited by 91
“Malhotra et al. (1995) showed that glycosylation changes of the IgG Fc domain were common in rheumatoid arthritis and that these IgG isoforms could activate complement through the mannose-binding protein pathway; no one has shown that this can occur with RBCs, but it is an interesting suggestion…”
BackgroundImpact of Differential Glycosylation on IgG Activity
Lux, A., & Nimmerjahn, F. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5632-3_10 · Cited by 91
“In vitro studies showed that a potential mechanism for this enhanced activity might be the exposure of the high mannose core sugar structure which could acquire the capacity to bind to mannan binding lectin (MBL), the first component of the lectin pathway of complement activation [ 73 ].”
BackgroundWang, M., Chen, Y., Zhang, Y., Zhang, L., Lu, X., & Chen, Z. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.1 · Cited by 89
Routier, F. H., Hounsell, E. F., Rudd, P. M., Takahashi, N., Bond, A., Hay, F. C., Alavi, A., Axford, J. S., & Jefferis, R. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00032-5 · Cited by 89
Self-citationUpdate on IgG4-mediated autoimmune diseases: New insights and new family members
Koneczny, I. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102646 · Cited by 88
Humoral Pattern Recognition Molecules: Mannan-Binding Lectin and Ficolins
Thiel, S., & Gadjeva, M. G. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0901-5_5 · Cited by 88
Matsuda, M., Shikata, K., Wada, J., Sugimoto, H., Shikata, Y., Kawasaki, T., & Makino, H. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000045212 · Cited by 86
“It has been reported that the glycosylation of the circulating IgG molecules changed in patients with rheumatoid arthritis [”
BackgroundGlobal variability of the human IgG glycome
Štambuk, J., Nakić, N., Vučković, F., Pučić‐Baković, M., Razdorov, G., Trbojević‐Akmačić, I., Novokmet, M., Keser, T., Vilaj, M. Ć., Štambuk, T., et al. (2020) · Aging · doi:10.18632/aging.103884 · Cited by 85
Initiation and Regulation of Complement during Hemolytic Transfusion Reactions
Stowell, S. R., Winkler, A. M., Maier, C. L., Arthur, C. M., Smith, N. H., Girard‐Pierce, K. R., Cummings, R. D., Zimring, J. C., & Hendrickson, J. E. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/307093 · Cited by 85
“For example, posttranslational glycosylation of the Fc domain can also impact the ability of IgG molecules to engage C1q or activate the lectin pathway of complement [76, 77].”
Background
Metadata
- Authors
- Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B.
- Affiliations
- University of Oxford (GB)
- Venue
- Nature Medicine
- Published
- 1995-03
- Volume
- 1
- Issue
- 3
- Pages
- 237-243
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2053863608
- Cited by
- 786
- References
- 33
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 17 · 2022: 34 · 2021: 29 · 2020: 25 · 2019: 32 · 2018: 35 · 2017: 34 · 2016: 32 · 2015: 27 · 2014: 36 · 2013: 36 · 2012: 29
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- rheumatoid arthritis, IgG glycosylation, mannose-binding protein, complement activation, Fc fragment, N-acetylglucosamine, synovitis, chronic inflammation
- MeSH terms
- Arthritis, Rheumatoid, Carbohydrate Sequence, Carrier Proteins, Complement Activation, Computer Simulation, Glycosylation, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Synovial Fluid, Mannose-Binding Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.